A big step has been taken to make sure that important medicines are always available. The government has given the green light to 48 special projects. This is part of a plan to help companies in the country make key ingredients for medicines. These substances are referred to as Key Starting Materials (KSMs), Drug Intermediates (DIs), and Active Pharmaceutical Ingredients (APIs). Think of APIs as the main part of a medicine that makes it work. By making more of these ingredients at home, we can avoid problems if supplies from other countries get stuck. This important move is all about making the country’s healthcare system stronger. It helps reduce how much we depend on just one place for these critical ingredients. This is extra important for medicines that don’t have other choices if their main ingredients run out. It’s like having a backup plan so that hospitals and doctors always have what they need to help people. The plan is designed to make sure that the manufacturing of these vital components happens right here, making the supply chain much more reliable. The project has already seen good progress. By December 2024, companies had put in a lot of money, more than what they first promised. This shows how serious they are about building up this important part of the manufacturing industry. With this investment, many new facilities are being set up or improved to produce these key components. This isn’t just good for medicine, but also for jobs and the economy, as it supports local businesses and workers. So far, the efforts have really paid off. Companies involved in this scheme have sold a lot of these ingredients, even sending some to other countries. This has also meant that less money is spent on buying these ingredients from abroad, which saves resources for the country. It’s a win-win situation, boosting local production and making sure there’s enough medicine for everyone. This kind of progress in the manufacturing sector directly helps the healthcare sector by providing a steady stream of necessary supplies.The program has effectively established local production for 25 various types of KSMs, DIs, and APIs. This means that for these specific ingredients, the country no longer has to worry as much about getting them from somewhere else. This strong base in pharmaceutical manufacturing is key to a stable healthcare system, ensuring that people get the medicines they need without delay. It’s a positive outlook for both the manufacturing industry and the health of the nation.
